Entera Bio Ltd. — Director's Dealing 2026

Feb 11, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. ([ENTX])
CIK: 0001638097
Period of Report: 2026-02-09

Reporting Person: Rubin Steven D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-09	Ordinary Shares, par value NIS 0.0000769 per share	P	10000	$1.20	Acquired	10000	Direct